Searched for
PHARMACY SECTOR
Financials in a sweet spot, defence remains a structural bet: Dharmesh KantFinancial stocks are set to lead a market rally through June and July. Experts see banks and financial institutions benefiting from strong ...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- India's healthcare transformed in 12 years under PM Modi: ReportIndia's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- From ₹5,000 salary to ₹48 crore turnover: Meet Nayana Vaidya, a pharma saleswoman, who built a healthcare distribution company from scratchNayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...
- Top-level rejig hits mid-cap ITs; Fintechs wary of RBI wallet rulesHappy Thursday! Mid-sized IT firms are realigning leadership teams as AI-driven changes force a rethink. This and more in today's ETtech Mo...
- Chemists’ strike: CDSCO moves to prevent shortagesThe CDSCO has advised state drug controllers to prevent drug scarcity during the AIOCD's proposed e-pharmacy strike on May 20. Measures inc...
- Online medicine sale fight: 20,000 chemists in Karnataka to halt work May 20Over 20,000 chemists in Karnataka will shut down their stores on May 20. This is part of a nationwide protest against online pharmacies. Th...
- All major pharmacy chains, hospital-based medical stores, Jan Aushadhi Kendras to remain open on May 20Pharmacies nationwide will stay open on May 20. This defies a strike called by the All India Organisation of Chemists and Druggists against...
- Pharmacy associations to skip strike, major medicine disruption unlikelyIndia's drug regulator is actively reviewing concerns from retail chemists about e-pharmacies. The All India Organisation of Chemists and D...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- NPS Swasthya: A cushion, not fill-in, for health coverCan the NPS Swasthya scheme be an effective substitute for a comprehensive health insurance plan that covers hospitalisation and related ex...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Revamped Tata Neu to bet on loyalty, financial services: Tata Digital CEO Sajith SivanandanTata Digital is pivoting Tata Neu from a broad commerce aggregator to a loyalty-led financial services platform, focusing on payments, inve...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
Load More
